FDA Adverse Event Malfunction Summary report: N

ARCHITECT C-PEPTIDE REAGENT

MDR report key: 2194245 · Received August 6, 2011

Report

Report Number
1415939-2011-00532
Event Type
Malfunction
Date Received
August 6, 2011
Report Date
June 30, 2011
Manufacturer
ABBOTT LABORATORIES
Product Code
JKD
PMA / PMN Number
EXEMPT
Removal / Correction Number
1415939-7/11/11-001-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4): HIGH TEST RESULTS. THE CAUSE OF THE ARCHITECT C-PEPTIDE FALSELY ELEVATED QUALITY CONTROLS AND PATIENT RESULTS WAS DUE TO A NEW ANTIBODY LOT USED IN THE MANUFACTURING OF THE C-PEPTIDE MICROPARTICLE AND/OR CONJUGATE REAGENTS. ABBOTT ISSUED A PRODUCT RECALL LETTER TO ALL CUSTOMERS WITH INSTRUCTIONS TO DISCARD AND DESTROY ANY REMAINING INVENTORY OF THE AFFECTED LOTS.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED A FALSELY ELEVATED ARCHITECT C-PEPTIDE PATIENT RESULT WHEN REAGENT LOT 00110L000 WAS IN USE. THE CUSTOMER WAS PERFORMING A CORRELATION BETWEEN THE LUMIPULSE F METHOD AND THE ARCHITECT C-PEPTIDE ASSAY AND OBSERVED THE DISCREPANT RESULT FOR A TYPE 1 DIABETIC PATIENT SAMPLE. ANOTHER SAMPLE FROM THE SAME PATIENT WAS TESTED AND A REPEAT ELEVATED RESULT WAS GENERATED EVEN AFTER CENTRIFUGATION OF THE SAMPLE. THE CUSTOMER ALSO TESTED ALIQUOT SAMPLES FROM THE SAME PATIENT WHICH WERE COLLECTED BEFORE AND AFTER A MEAL. THE CUSTOMER ALSO OBSERVED POOR DILUTION LINEARITY WITH THE SUSPECT SAMPLE, THEREFORE, THE CUSTOMER DECIDED THERE WAS A HIGH POSSIBILITY OF NON SPECIFIC REACTION OF THE DIABETIC PATIENT SAMPLE WITH THE ARCHITECT C-PEPTIDE ASSAY. THERE WAS NO IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT C-PEPTIDE REAGENT JKD ABBOTT LABORATORIES 00110L000

Patients

Seq Age Sex Outcome Treatment
1 LUMIPULSE F C-PEPTIDE ASSAY| ARCHITECT I1000SR ANALYZER, LIST # 1L86-01